0000885590-13-000025 Sample Contracts

FIFTH SUPPLEMENTAL INDENTURE

Supplemental Indenture • May 3rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Supplemental Indenture
• Filed
  May 3rd, 2013
• Company
  Valeant Pharmaceuticals International, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

FIFTH SUPPLEMENTAL INDENTURE, dated as of April 23, 2013 (the “Fifth Supplemental Indenture”), by and among Medicis Pharmaceutical Corporation (“Medicis”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).

FIFTH SUPPLEMENTAL INDENTURE

Fifth Supplemental Indenture • May 3rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Fifth Supplemental Indenture
• Filed
  May 3rd, 2013
• Company
  Valeant Pharmaceuticals International, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

FIFTH SUPPLEMENTAL INDENTURE, dated as of April 23, 2013 (the “Fifth Supplemental Indenture”), by and among Medicis Pharmaceutical Corporation (“Medicis”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).

SIXTH SUPPLEMENTAL INDENTURE

Sixth Supplemental Indenture • May 3rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Sixth Supplemental Indenture
• Filed
  May 3rd, 2013
• Company
  Valeant Pharmaceuticals International, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

SIXTH SUPPLEMENTAL INDENTURE, dated as of April 23, 2013 (the “Sixth Supplemental Indenture”), by and among Medicis Pharmaceutical Corporation (“Medicis”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).

SECOND SUPPLEMENTAL INDENTURE

Second Supplemental Indenture • May 3rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Second Supplemental Indenture
• Filed
  May 3rd, 2013
• Company
  Valeant Pharmaceuticals International, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

SECOND SUPPLEMENTAL INDENTURE, dated as of April 23, 2013 (the “Second Supplemental Indenture”), by and among Medicis Pharmaceutical Corporation (“Medicis”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).

SEVENTH SUPPLEMENTAL INDENTURE

Seventh Supplemental Indenture • May 3rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Seventh Supplemental Indenture
• Filed
  May 3rd, 2013
• Company
  Valeant Pharmaceuticals International, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

SEVENTH SUPPLEMENTAL INDENTURE, dated as of April 23, 2013 (the “Seventh Supplemental Indenture”), by and among Medicis Pharmaceutical Corporation (“Medicis”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”) and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).

FIRST SUPPLEMENTAL INDENTURE

First Supplemental Indenture • May 3rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York

• Contract Type
  First Supplemental Indenture
• Filed
  May 3rd, 2013
• Company
  Valeant Pharmaceuticals International, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

FIRST SUPPLEMENTAL INDENTURE, dated as of April 23, 2013 (the “First Supplemental Indenture”), by and among Medicis Pharmaceutical Corporation (“Medicis”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).